Synlogic, Inc.

DB:MIN Stock Report

Market Cap: €30.4m

Synlogic Management

Management criteria checks 3/4

Synlogic's CEO is Aoife Brennan, appointed in May 2018, has a tenure of 5.58 years. total yearly compensation is $1.68M, comprised of 35.3% salary and 64.7% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth €56.49K. The average tenure of the management team and the board of directors is 2.9 years and 6.3 years respectively.

Key information

Aoife Brennan

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage35.3%
CEO tenure5.6yrs
CEO ownership0.2%
Management average tenure2.9yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Aoife Brennan's remuneration changed compared to Synlogic's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$65m

Mar 31 2023n/an/a

-US$66m

Dec 31 2022US$2mUS$595k

-US$66m

Sep 30 2022n/an/a

-US$65m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$61m

Dec 31 2021US$2mUS$570k

-US$61m

Sep 30 2021n/an/a

-US$60m

Jun 30 2021n/an/a

-US$57m

Mar 31 2021n/an/a

-US$58m

Dec 31 2020US$1mUS$550k

-US$59m

Sep 30 2020n/an/a

-US$57m

Jun 30 2020n/an/a

-US$57m

Mar 31 2020n/an/a

-US$54m

Dec 31 2019US$2mUS$505k

-US$51m

Sep 30 2019n/an/a

-US$51m

Jun 30 2019n/an/a

-US$48m

Mar 31 2019n/an/a

-US$50m

Dec 31 2018US$2mUS$451k

-US$48m

Sep 30 2018n/an/a

-US$48m

Jun 30 2018n/an/a

-US$49m

Mar 31 2018n/an/a

-US$44m

Dec 31 2017US$1mUS$349k

-US$40m

Sep 30 2017n/an/a

-US$36m

Jun 30 2017n/an/a

-US$29m

Mar 31 2017n/an/a

-US$24m

Dec 31 2016US$386kUS$115k

-US$21m

Compensation vs Market: Aoife's total compensation ($USD1.68M) is above average for companies of similar size in the German market ($USD427.28K).

Compensation vs Earnings: Aoife's compensation has been consistent with company performance over the past year.

CEO

Aoife Brennan (47 yo)

5.6yrs

Tenure

US$1,684,450

Compensation

Dr. Aoife M. Brennan, M.D. M.B., Ch B., BAO, MMSc, MRCPI, serves as Director at FibroGen, Inc. since August 5, 2020. Dr. Brennan serves as Director at Cerevance LLC.from January 1, 2020. She served as Dir...

Leadership Team

NamePositionTenureCompensationOwnership
Aoife Brennan
President5.6yrsUS$1.68m0.19%
€ 56.5k
Antoine Awad
Chief Operating Officer3.4yrsUS$876.33k0.054%
€ 16.5k
Timothy Lu
Co-Founder & Member of Scientific Advisory Boardno datano datano data
James Collins
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Mary Dooley
VP & Head of Financeless than a yearno datano data
Brendan Amant
General Counsel & Corporate Secretary2.9yrsno datano data
Ajay Munshi
Vice President of Corporate Developmentno datano datano data
Adam Thomas
Chief People Officer6.2yrsno datano data
Caroline Kurtz
Chief Development Officer7.3yrsno datano data
Molly Harper
Chief Business Officer2.3yrsno datano data
Neal Sondheimer
VP & Head of Clinicalless than a yearno datano data
Mylene Perreault
VP & Head of Researchless than a yearno datano data

2.9yrs

Average Tenure

46yo

Average Age

Experienced Management: MIN's management team is considered experienced (2.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Aoife Brennan
President5.2yrsUS$1.68m0.19%
€ 56.5k
Timothy Lu
Co-Founder & Member of Scientific Advisory Boardno datano datano data
James Collins
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Richard Shea
Independent Director6.3yrsUS$77.02k0.0054%
€ 1.7k
Peter Barrett
Independent Chairman of the Board9.4yrsUS$103.52k0%
€ 0
Edward Mathers
Independent Director11.2yrsUS$67.02k0%
€ 0
Michael Heffernan
Independent Director3yrsUS$77.52k0%
€ 0
Nick Leschly
Independent Director7.8yrsUS$67.02k0.017%
€ 5.1k
Lisa Kelly-Croswell
Independent Director2.8yrsUS$77.20k0%
€ 0
Paul Miller
Member Scientific Advisory Boardno dataUS$956.81kno data
Charlotte Hubbert
Observerno datano datano data
Cammie Lesser
Member of Scientific Advisory Boardno datano datano data

6.3yrs

Average Tenure

58yo

Average Age

Experienced Board: MIN's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/26 13:17
End of Day Share Price 2023/09/28 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Synlogic, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher HowertonJefferies LLC
Joseph SchwartzLeerink Partners LLC
Mark BreidenbachOppenheimer & Co. Inc.